Pharmafile Logo
Pharmafocus logo
Advanced Search
eugene_washington-iha-005108

Eugene Washington appointed to J&J Board of directors

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ

Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …

Appointment

AstraZeneca signs genome deal

November 13, 2012
Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …

News

EFCG calls for mandatory inspection of API plants

November 13, 2012
Manufacturing and Production API, EFCG, EU, FMD

The European Fine Chemicals Group (EFCG) has called for all active pharmaceutical ingredient (API) manufacturing facilities to undergo mandatory inspections. …

News
Hospira image

Hospira on track to return propofol to market

November 13, 2012
Manufacturing and Production Ball, Hospira, Teva

Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …

News
coulthard

NHS Commissioning Board appoints Patients and Information directors

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board

The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …

Appointment
kb

Pharma can help NHS transition, says partnership leader

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CCGs, Conference, NHS, PCT

A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …

Feature

Patients ‘shut out’ of drug price talks

November 13, 2012
Sales and Marketing Cancer, NHS, NICE, VBP, prostate

Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …

News
Pfizer image

Pfizer and GSK end agreements

November 12, 2012
Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport

Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …

News

Havas Health launches new Global Agency Group, Havas Lynx

November 12, 2012
Medical Communications

 Euro RSCG Life 4D and Creative Lynx join to form new Global Brand for the next era in Health and …

News
Press release

Contract research news in brief

November 12, 2012
Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River

Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.

News
board_peter_chambre

immatics appoints Peter Chambré as chairman

November 12, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics

Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …

Appointment
NHS image

NHS: pharma needs to help more

November 12, 2012
Sales and Marketing CCGs, NHS, pharma

A variety of senior figures in public health set out how they want the pharma industry to do more to …

News
copper image

Copper could replace precious metals in pharma production

November 9, 2012
Manufacturing and Production Sweden, copper, manufacturing

Non-precious metals such as copper could be used as catalysts in pharmaceuticals production, replacing precious metals that are expensive and …

News
Revolade image

GSK guilty of off-label promotion

November 9, 2012
Medical Communications, Sales and Marketing GSK, PMCPA, Revolade

GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …

News
stephen whitehead image

Pharma treated as though ‘selling cyanide’

November 9, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …

News

Astellas appoints VP of Scientific and Medical Affairs

November 9, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …

Appointment
speakerwilliamsmarth

Leadership changes at Teva

November 8, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …

Appointment
janssen image

Janssen and GSK in hep C tie-ups

November 8, 2012
Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …

News
bad pharma image

Goldacre is right – greater honesty is needed

November 7, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …

Feature

‘Patchy’ NHS Constitution needs improving

November 7, 2012
Sales and Marketing DoH, Future Forum, NHS, commissioning

The NHS Future Forum has criticised the NHS Constitution for not being up to scratch and suggested ‘essential steps’ to …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026